Dado oficial do INPI

TENULI

Essa marca aparece no histórico oficial do INPI.

Mesmo quando o status está encerrado, o histórico ajuda a calibrar o risco, evitar repetição de erros e definir uma estratégia segura de naming.

Aguardando exame de méritoTipo: VerbalEscritório: Brasil

Ativar vigilância desta marca Falar com especialista

Snapshot rápido

TENULI

ST13

BR500000501869366

Classe

Pedido

501869366

Registro

501869366

Ver no INPI

Andamento no INPI

Depósito24/10/25
Publicação18/02/26
Exame
Deferimento
Concessão
Vigente

Publicado em 18/02/2026, o pedido aguarda a decisão de mérito do INPI: deferimento ou indeferimento.

Última movimentação publicada pelo INPI: 18/02/2026. Atualizamos a cada nova RPI, publicada semanalmente.

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação INPI

Aguardando exame de mérito

Tipo de processo

Pedido de registro

Eventos registrados

Atualização mais recente

18/02/2026

Tipo de marca

Verbal

Classes Nice

Data de depósito

24/10/2025

Data de registro

Data de expiração

11/07/2035

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Natureza

Madri Produto/Serviço

Escritório responsável

Brasil

Tipo de titular

NÃO RESIDENTE

Localização do titular

Titulares e representantes

Titulares

Bausch Health Ireland Limited

Representantes

Sem dados de representantes.

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations and substancespharmaceutical preparations for the prevention and treatment of allergiespharmaceutical preparations for the prevention and treatment of autoimmune conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of blood conditions, diseases and disorderspharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorderspharmaceutical preparations for the prevention and treatment of conditions, diseases, and disorders of the central and peripheral nervous systempharmaceutical preparations for the prevention and treatment of dermatological conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of endocrine conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of gastrointestinal conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of hepatic conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of immunological conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of infectious diseasespharmaceutical preparations for the prevention and treatment of inflammatory conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of metabolic conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of muscular conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of neurological conditions, diseases, and disorderspharmaceutical preparations for the treatment of painpharmaceutical preparations for the prevention and treatment of psychiatric conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of respiratory and pulmonary conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of renal conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of urological conditions, diseases, and disorderspharmaceutical preparations for the prevention and treatment of viral diseases